Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Yoanna Ariosa-Morejon has joined the Arthritis Research UK Centre for OA Pathogenesis at the Kennedy Institute this January to investigate the 'Turnover and incorporation of new Type II collagen in normal and diseased cartilage', with Professor Tonia Vincent.

Daphne Jackson Fellowships are a unique scheme designed to return STEM professionals to their careers after a break. The Fellowships are flexible and include a tailored training programme designed to update skills and knowledge and support the Fellows in their return to research.

Thanks to the Daphne Jackson program and my sponsors, the Kennedy Trust and University of Oxford I will be able to return to research after four years of career break. - Dr Yoanna Ariosa-Morejon

Dr Yoanna Ariosa-Morejon will develop a challenging research project at the Kennnedy Institute, supported by Professor Vincent and her research group and co-supervisor Dr. John Christianson, from the Ludwig Cancer Research Institute.

Type II collagen has a reported half life of more than 100 years. This is thought to be a principal reason why cartilage has poor reparative capacity. Yoanna's project will use in vitro and in vivo techniques to ask what factors determine the amount and quality of type II collagen laid down before skeletal maturity, and whether repairing cartilage has the capacity to incorporate new type II collagen later in life.

Professor Vincent says: "We are delighted to embrace the Daphne Jackson Fellowship Scheme and welcome Yoanna into our OA Pathogenesis Centre. Yoanna's project addresses one of the most challenging and important issues of cartilage health - namely, does adult cartilage repair once it is damaged, and to what extent is this process limited by the negligible turnover of collagen in adult tissue".

Yoanna received scientific training at the Universidad Autónoma de Madrid and has held Research Scientist positions in both academia and industry. Before taking a career break to care for her young children, she most recently worked at a start-up Biotech company focusing on development of vaccines against fungal allergies.

Speaking of the award, Yoanna says: "Thanks to the Daphne Jackson program and my sponsors, the Kennedy Trust and University of Oxford I will be able to return to research after four years of career break. I'm really pleased and the Kennedy is such a vibrant place to work! Also, I have been fully supported during the whole process by both my advisor from the Daphne Jackson Trust and my supervisors at Oxford, I feel very fortunate"

The Daphne Jackson Trust, which runs the Fellowship scheme, aims to return researchers to their careers, helping retain a talented STEM workforce by offering flexible fellowships with mentoring and training to allow women and men to return to research after a career break of 2 or more years, for family, caring or health reasons. It supports equality and diversity in the research workforce and aims to develop partnerships that extend the reach and increase the impact of flexible working opportunities for STEM researchers.

The University of Oxford and the Kennedy Trust for Rheumatology Research jointly sponsor this Daphne Jackson Fellowship.

Similar stories

Single-cell ancestry vaccine research funded by the Chan Zuckerberg Initiative

The Chan Zuckerberg Initiative (CZI) has provided $2 million in funding to investigate how our ancestry and diversity influence the way that vaccines work in our cells.

Novo Nordisk Postdoctoral Research Fellowship awarded to Inhye Park

Inhye Park has been awarded a Novo Nordisk Postdoctoral Research Fellowship to research the biology of resident vascular macrophages in atherosclerosis.

Researchers from the Kennedy Institute awarded MRC funding

Tonia Vincent, Jelena Bezbradica and Alex Clarke have been awarded funding grants by the Medical Research Council (MRC) for different projects.

EPSRC funds research to avert an antibiotics apocalypse

Researchers at the Kennedy Institute join a collaboration to find new ‘drug-free’ ways of treating illnesses where current treatments have become ineffective due to antibiotic resistance.

Major ERC funding awarded to Professor Michael Dustin

Professor Michael Dustin and an international team of collaborators have been awarded a €10M grant from the European Research Council (ERC) to develop a new biotechnology around supramolecular attack particles (SMAPs) engineered to kill cancer cells.

Oxford University awarded £2.4 million to fund DPhil research in inflammation, immunology and musculoskeletal disease

Oxford University has today been awarded a £2.4 million grant, as part of the Kennedy Trust MB PhD scheme, to fund undergraduate medical students to undertake DPhil research in the areas of inflammation, immunology and musculoskeletal disease.